A Case of Kaposi's Sarcoma on Oropharynx and Hypopharynx in Human Immunodeficiency Virus-Negative Patient.
10.3342/kjorl-hns.2012.55.1.50
- Author:
Kyung Jin NA
1
;
Dongbin AHN
;
Jun Ho SEOK
;
Junesik PARK
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyungpook National University, Daegu, Korea. entgodlikeu@gmail.com
- Publication Type:Case Report
- Keywords:
Kaposi's sarcoma;
Oropharynx;
Hypopharynx;
Capecitabine;
HHV-8
- MeSH:
Acquired Immunodeficiency Syndrome;
Aged;
Deoxycytidine;
Fluorouracil;
Head;
Herpesvirus 8, Human;
HIV;
Humans;
Hypopharynx;
Neck;
Oropharynx;
Sarcoma, Kaposi;
Capecitabine
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2012;55(1):50-54
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The number of patients diagnosed with Kaposi's sarcoma has grown steadily since it was first discovered in 1972 by Moric Kaposi, a Hungarian dermatologist. Kaposi's sarcoma can be classified into four subtypes according to clinical form, epidemiology, and prognosis: idiopathic, endemic or African, immunosuppresion related, and acquired immunodeficiency syndrome related or epidemic Kaposi's sarcoma. A single idiopathic Kaposi's sarcoma in the head and neck area is very rarely found in an immunocompetent person. We experienced a case of Kaposi's sarcoma of the oropharynx and hypopharynx. The patient was healthy 70-year-old man and had no signs of being human immunodeficiency virus positive or immunocompromised. The patient was treated with inductive chemotherapy using capecitabine (Xeloda(R))/cisplatin followed by radiotherapy to a total 54 Gy.
